Eruptive Xanthome
Elvir Cesko(Essen University Hospital), Thomas Jansen(Ruhr University Bochum), Andreas Körber(Ruhrlandklinik), Joachim Dissemond(Essen University Hospital), Lisa Rappoport, Nadine Voshege, Sarah Piel(Düsseldorf University Hospital), Julia Freise(Medizinische Hochschule Hannover)
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
|Seminars in Oncology|2010|170
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
|Nature Communications|2016|153